Rotavirus Vaccine Access and Delivery

Accelerating access to rotavirus vaccines

A lifeline for children in the world’s poorest countries

Yemeni child receiving rotavirus vaccine.

Photo: GAVI/Amira Al-Sharif.

Diarrhea is a leading killer of young children worldwide, and rotavirus is the most common cause of severe diarrhea. Each year, rotavirus kills more than 450,000 children younger than five years of age and hospitalizes millions more. Countries that have introduced rotavirus vaccines have experienced reductions in severe and fatal diarrhea, underscoring the incredible potential for rotavirus vaccines to improve child health and save lives.


Resources on this site


Sign up for RotaFlash e-news alert

PATH’s RotaFlash is an e-news alert that provides breaking scientific news and updates on progress made by PATH and partners toward increasing global access to vaccines against rotavirus, the leading cause of severe diarrhea in young children worldwide.

Learn more

Sign up for RotaFlash and access the latest issues.


PATH’s approach: Providing expertise, tools, and evidence to support rotavirus vaccine access and sustainability  

PATH is working to accelerate access to rotavirus vaccines and sustain their implementation and use in countries where children need them most urgently by:

  • Increasing awareness of the burden of rotavirus disease and demonstrating that rotavirus vaccines play an essential and lifesaving role in comprehensive diarrhea control strategies.
  • Generating and disseminating information at the global and country level to help policymakers make informed, evidence-based decisions on the introduction, implementation, and sustained use of rotavirus vaccines.
  • Conducting scientific studies to increase effectiveness of existing commercial rotavirus vaccines.
  • Speeding the development of promising candidates into safe, effective, and affordable rotavirus vaccines.

Learn more

Comments are closed.